Overall Survival and Progression-Free Survival in Patients With Primary Brain Tumors After Treatment: Is the Outcome of [18F] FDOPA PET a Prognostic Factor in These Patients?
Annals of Nuclear Medicine - Japan
doi 10.1007/s12149-019-01355-8
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2019
Authors
Publisher
Springer Science and Business Media LLC